HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Aniline → 2-(6-chloro-1-methyl-1H-indazol-3-yl)-N-phenyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide

HRID 246600
Print

Reaction equation

HRID 246600 reaction equation
[Cl:1][C:2]1[CH:10]=[C:9]2[C:5]([C:6]([C:12]3[N:13]=[C:14]4[C:20]([C:21]([OH:23])=O)=[CH:19][NH:18][C:15]4=[N:16][CH:17]=3)=[N:7][N:8]2[CH3:11])=[CH:4][CH:3]=1.[NH2:24][C:25]1[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=1.CCN=C=NCCCN(C)C.CCN(C(C)C)C(C)C.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN(C1C=CN=CC=1)C.CN(C=O)C>[Cl:1][C:2]1[CH:10]=[C:9]2[C:5]([C:6]([C:12]3[N:13]=[C:14]4[C:20]([C:21]([NH:24][C:25]5[CH:30]=[CH:29][CH:28]=[CH:27][CH:26]=5)=[O:23])=[CH:19][NH:18][C:15]4=[N:16][CH:17]=3)=[N:7][N:8]2[CH3:11])=[CH:4][CH:3]=1
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

8

Reactant 5

HCID 6115AnilineHCID 159081-Ethyl-3-(3'-dimethylaminopropyl)carbodiimideHCID 81531DiisopropylethylamineHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 712800962-(6-chloro-1-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid

Product 1

HCID 712796492-(6-chloro-1-methyl-1H-indazol-3-yl)-N-phenyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxamideYield 29%

Reagents, catalysts & solvents 2

HCID 142844-(Dimethylamino)pyridineCatalystHCID 6228DimethylformamideSolvent

Procedure

A mixture of 2-(6-chloro-1-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid (0.07 g, 0.3 mmol), aniline (0.05 g, 0.54 mmol), EDCI (0.057 g, 0.3 mmol), DMAP (0.037 g, 0.3 mmol), and DIPEA (0.163 g, 1.26 mmol) in 10 mL of DMF was stirred at room temperature for 5 hours. And then HATU (0.114 g, 0.3 mmol) was added, the final reaction mixture was stirred for 15 hours. The solvent was removed under reduced pressure at 70° C. The residue was triturated with water and then purified by preparative-HPLC (Gemini 5u C18 150×21.2 mm; inject volume: 3 mL/inj, flow rate: 20 mL/min; wavelength: 214 nm and 254 nm; the gradient conditions were: 65% acetonitrile/35% water (0.1% trifluoroacetic acid, v/v) initially, proceeding to 72% acetonitrile/28% water (0.1% trifluoroacetic acid, v/v) in a linear fashion over 9 min.) to give 2-(6-chloro-1-methyl-1H-indazol-3-yl)-N-phenyl-5H-pyrrolo[2,3-b]pyrazine-7-carboxamide (0.025 g, 29%) as a white solid. MS: (M+H)+=403; 1H NMR (300 MHz, DMSO): δ 10.21 (s, 1H), 9.12 (s, 1H), 8.63-8.58 (m, 2H), 8.42 (brs, 2H), 8.04 (s, 1H), 7.83-7.80 (m, 2H), 7.49-7.43 (m, 2H), 7.30 (d, 1H, J=8.7 Hz), 7.17 (d, 1H, J=7.2 Hz), 4.21 (s, 3H).

Workup

  1. customthe final reaction mixture
  2. stirringwas stirred for 15 hours
  3. customThe solvent was removed under reduced pressure at 70° C
  4. customThe residue was triturated with water
  5. custompurified by preparative-HPLC (Gemini 5u C18 150×21.2 mm
  6. wait65% acetonitrile/35% water (0.1% trifluoroacetic acid, v/v) initially, proceeding to 72% acetonitrile/28% water (0.1% trifluoroacetic acid, v/v) in a linear fashion over 9 min.

Sources & evidence

ORD record
ord-58ec797298ba492a96a5a76568928180
Source dataset
uspto-grants-2014_02
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08658646B2

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes